Eton Pharmaceuticals, Inc. ($ETON)
Erdogan-Trinkaus Ipek โ Chief Commercial Officer
Shares
2,340
Price
$67.18
Total Value
$157,198.16
Nearby Earnings
Nov 5, 2026
EPS:Est: 0.31
Revenue:Est: $41.98M
Transaction Details
| Insider | Erdogan-Trinkaus Ipek |
|---|---|
| Title | Chief Commercial Officer |
| Transaction Date | Nov 10, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Nov 12, 2026 |
| Shares Sold | 2,340 |
| Price per Share | $67.18 |
| Total Value | $157,198.16 |
| Shares Owned After | 5,241 |
| Derivative | No |
| Accession Number | 0001437749-26-036605 |
| Document | View SEC Filing |